Clear Cell Renal Cell Carcinoma 2022–2023
Clear cell renal cell carcinoma is a common tumor in Western countries and an appropriate test subject for new therapies. This Special Issue highlights the most up-to-date research into clear cell renal cell carcinoma from different medical perspectives, including its diagnosis, prognosis, and treat...
-д хадгалсан:
| Формат: | Online |
|---|---|
| Хэл сонгох: | англи |
| Хэвлэсэн: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Нөхцлүүд: | |
| Онлайн хандалт: | ONIX_20240514_9783725804757_320 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
| _version_ | 1869526464276201472 |
|---|---|
| collection | Directory of Open Access Books |
| description | Clear cell renal cell carcinoma is a common tumor in Western countries and an appropriate test subject for new therapies. This Special Issue highlights the most up-to-date research into clear cell renal cell carcinoma from different medical perspectives, including its diagnosis, prognosis, and treatment. |
| format | Online |
| id | doab-20.500.12854ir-137724 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1377242024-05-14T14:15:27Z Clear Cell Renal Cell Carcinoma 2022–2023 López, José I. Manini, Claudia TIME (tumor immune microenvironment) synchronous metachronous mRCC (metastatic renal cell carcinoma) PD-L1 immunophenotype imaging renal cell carcinoma biomarker renal mass radiomics radiogenomics circadian rhythm clock genes immunotherapy HIF immune microenvironment tumor immunology immune checkpoint inhibitor cystic renal neoplasm differential diagnosis single-cell RNA-seq cell-of-origin tumor microenvironment stromal cells immune cells novel therapies predictive biomarkers prognostic biomarkers therapeutic monitoring immune checkpoint inhibitors VEGF inhibitors metastatic disease nitric oxide signalling ccRCC cohort study partial nephrectomy radical nephrectomy perioperative outcomes mortality tumor heterogeneity T cell mRCC complement classical pathway “aggressive complement” tumor biomarkers cancer cholesterol LDL HDL VLDL NPC1 TKI indirect comparison Shiny method reconstructed individual patient data disease-free survival adjuvant setting n/a thema EDItEUR::P Mathematics and Science::PB Mathematics::PBW Applied mathematics Clear cell renal cell carcinoma is a common tumor in Western countries and an appropriate test subject for new therapies. This Special Issue highlights the most up-to-date research into clear cell renal cell carcinoma from different medical perspectives, including its diagnosis, prognosis, and treatment. 2024-05-14T14:15:15Z 2024-05-14T14:15:15Z 2024 book ONIX_20240514_9783725804757_320 9783725804757 9783725804764 https://directory.doabooks.org/handle/20.500.12854/137724 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/8953 https://mdpi.com/books/pdfview/book/8953 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-0476-4 10.3390/books978-3-7258-0476-4 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725804757 9783725804764 220 open access |
| spellingShingle | TIME (tumor immune microenvironment) synchronous metachronous mRCC (metastatic renal cell carcinoma) PD-L1 immunophenotype imaging renal cell carcinoma biomarker renal mass radiomics radiogenomics circadian rhythm clock genes immunotherapy HIF immune microenvironment tumor immunology immune checkpoint inhibitor cystic renal neoplasm differential diagnosis single-cell RNA-seq cell-of-origin tumor microenvironment stromal cells immune cells novel therapies predictive biomarkers prognostic biomarkers therapeutic monitoring immune checkpoint inhibitors VEGF inhibitors metastatic disease nitric oxide signalling ccRCC cohort study partial nephrectomy radical nephrectomy perioperative outcomes mortality tumor heterogeneity T cell mRCC complement classical pathway “aggressive complement” tumor biomarkers cancer cholesterol LDL HDL VLDL NPC1 TKI indirect comparison Shiny method reconstructed individual patient data disease-free survival adjuvant setting n/a thema EDItEUR::P Mathematics and Science::PB Mathematics::PBW Applied mathematics Clear Cell Renal Cell Carcinoma 2022–2023 |
| title | Clear Cell Renal Cell Carcinoma 2022–2023 |
| title_full | Clear Cell Renal Cell Carcinoma 2022–2023 |
| title_fullStr | Clear Cell Renal Cell Carcinoma 2022–2023 |
| title_full_unstemmed | Clear Cell Renal Cell Carcinoma 2022–2023 |
| title_short | Clear Cell Renal Cell Carcinoma 2022–2023 |
| title_sort | clear cell renal cell carcinoma 2022 2023 |
| topic | TIME (tumor immune microenvironment) synchronous metachronous mRCC (metastatic renal cell carcinoma) PD-L1 immunophenotype imaging renal cell carcinoma biomarker renal mass radiomics radiogenomics circadian rhythm clock genes immunotherapy HIF immune microenvironment tumor immunology immune checkpoint inhibitor cystic renal neoplasm differential diagnosis single-cell RNA-seq cell-of-origin tumor microenvironment stromal cells immune cells novel therapies predictive biomarkers prognostic biomarkers therapeutic monitoring immune checkpoint inhibitors VEGF inhibitors metastatic disease nitric oxide signalling ccRCC cohort study partial nephrectomy radical nephrectomy perioperative outcomes mortality tumor heterogeneity T cell mRCC complement classical pathway “aggressive complement” tumor biomarkers cancer cholesterol LDL HDL VLDL NPC1 TKI indirect comparison Shiny method reconstructed individual patient data disease-free survival adjuvant setting n/a thema EDItEUR::P Mathematics and Science::PB Mathematics::PBW Applied mathematics |
| topic_facet | TIME (tumor immune microenvironment) synchronous metachronous mRCC (metastatic renal cell carcinoma) PD-L1 immunophenotype imaging renal cell carcinoma biomarker renal mass radiomics radiogenomics circadian rhythm clock genes immunotherapy HIF immune microenvironment tumor immunology immune checkpoint inhibitor cystic renal neoplasm differential diagnosis single-cell RNA-seq cell-of-origin tumor microenvironment stromal cells immune cells novel therapies predictive biomarkers prognostic biomarkers therapeutic monitoring immune checkpoint inhibitors VEGF inhibitors metastatic disease nitric oxide signalling ccRCC cohort study partial nephrectomy radical nephrectomy perioperative outcomes mortality tumor heterogeneity T cell mRCC complement classical pathway “aggressive complement” tumor biomarkers cancer cholesterol LDL HDL VLDL NPC1 TKI indirect comparison Shiny method reconstructed individual patient data disease-free survival adjuvant setting n/a thema EDItEUR::P Mathematics and Science::PB Mathematics::PBW Applied mathematics |
| url | ONIX_20240514_9783725804757_320 |